Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3835)
All Articles published online
|
Nov 21, 2005 (publication date) through Apr 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bani-Hani KE, Bani-Hani BK, Martin IG. Characteristics of patients with columnar-lined Barrett’s esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol 2005; 11(43): 6807-6814 [PMID: 16425388 DOI: 10.3748/wjg.v11.i43.6807] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i43/6807.htm |
| Number | Citing Articles |
| 1 |
A Kahn, M Al-Qaisi, V T Kommineni, J K Callaway, E S Boroff, G E Burdick, D M Lam-Himlin, M Temkit, M F Vela, F C Ramirez. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Diseases of the Esophagus 2018; 31(4) doi: 10.1093/dote/dox120
|
| 2 |
Neel Sharma, Khek Yu Ho. Columnar lined Barrett's oesophagus. British Journal of Hospital Medicine 2015; 76(12): 703 doi: 10.12968/hmed.2015.76.12.703
|
| 3 |
S Zhang, X-Q Zhang, X-W Ding, R-K Yang, S-L Huang, F Kastelein, M Bruno, X-J Yu, D Zhou, X-P Zou. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a meta-analysis. British Journal of Cancer 2014; 110(9): 2378 doi: 10.1038/bjc.2014.127
|
| 4 |
Sachin Wani, Gary Falk, Matthew Hall, Srinivas Gaddam, Amy Wang, Neil Gupta, Mandeep Singh, Vikas Singh, Keng–Yu Chuang, Vikram Boolchand, Hemanth Gavini, John Kuczynski, Priti Sud, Savio Reddymasu, Ajay Bansal, Amit Rastogi, Sharad C. Mathur, Patrick Young, Brooks Cash, David A. Lieberman, Richard E. Sampliner, Prateek Sharma. Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma. Clinical Gastroenterology and Hepatology 2011; 9(3): 220 doi: 10.1016/j.cgh.2010.11.008
|
| 5 |
Zhifeng Lou, Haibo Xing, Da Li, Ken-ichi Mukaisho. Alcohol Consumption and the Neoplastic Progression in Barrett's Esophagus: A Systematic Review and Meta-Analysis. PLoS ONE 2014; 9(10): e105612 doi: 10.1371/journal.pone.0105612
|
| 6 |
Muhammad H. Zeb, Anushka Baruah, Sarah K. Kossak, Navtej S. Buttar. Chemoprevention in Barrett’s Esophagus. Gastroenterology Clinics of North America 2015; 44(2): 391 doi: 10.1016/j.gtc.2015.02.009
|
| 7 |
David Armstrong. Should patients with Barrett's oesophagus be kept under surveillance? The case for. Best Practice & Research Clinical Gastroenterology 2008; 22(4): 721 doi: 10.1016/j.bpg.2008.03.002
|
| 8 |
Licia Pensabene, Marta C. Cohen, Michael Thomson. Clinical Implications of Molecular Changes in Pediatric Barrett’s Esophagus. Current Gastroenterology Reports 2012; 14(3): 253 doi: 10.1007/s11894-012-0252-x
|
| 9 |
Kamal E Bani‐Hani, Bayan K Bani‐Hani. Columnar lined (Barrett's) esophagus: Future perspectives. Journal of Gastroenterology and Hepatology 2008; 23(2): 178 doi: 10.1111/j.1440-1746.2007.05137.x
|
| 10 |
Dipesh Solanky, Rajesh Krishnamoorthi, Nicholas Crews, Michele Johnson, Kenneth Wang, Herbert Wolfsen, David Fleischer, Francisco C. Ramirez, David Katzka, Navtej Buttar, Prasad G. Iyer. Barrett Esophagus Length, Nodularity, and Low-grade Dysplasia are Predictive of Progression to Esophageal Adenocarcinoma. Journal of Clinical Gastroenterology 2019; 53(5): 361 doi: 10.1097/MCG.0000000000001027
|
| 11 |
Ayesha Noorani, Rebecca C. Fitzgerald. Esophageal cancer and barrett's esophagus. 2015; : 55 doi: 10.1002/9781118655153.ch6
|
| 12 |
Ganapathy A Prasad, Ajay Bansal, Prateek Sharma, Kenneth K Wang. Predictors of Progression in Barrett's Esophagus: Current Knowledge and Future Directions. American Journal of Gastroenterology 2010; 105(7): 1490 doi: 10.1038/ajg.2010.2
|
| 13 |
Mie Thu Ko, Tom Thomas, Emily Holden, Ian L.P. Beales, Leo Alexandre. The Association Between Obesity and Malignant Progression of Barrett’s Esophagus: A Systematic Review and Dose-Response Meta-Analysis. Clinical Gastroenterology and Hepatology 2025; 23(5): 726 doi: 10.1016/j.cgh.2024.07.041
|
| 14 |
E A Griffiths, S A Pritchard, S M McGrath, H R Valentine, P M Price, I M Welch, C M L West. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence. British Journal of Cancer 2007; 96(9): 1377 doi: 10.1038/sj.bjc.6603744
|
| 15 |
Pieter Jan F de Jonge, Mark van Blankenstein, William M Grady, Ernst J Kuipers. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut 2014; 63(1): 191 doi: 10.1136/gutjnl-2013-305490
|
| 16 |
David C Whiteman, Bradley J Kendall. Barrett's oesophagus: epidemiology, diagnosis and clinical management. Medical Journal of Australia 2016; 205(7): 317 doi: 10.5694/mja16.00796
|
| 17 |
Kamal E Bani‐Hani, Bayan K Bani‐Hani. Columnar‐lined esophagus: Time to drop the eponym of “Barrett”: Historical review. Journal of Gastroenterology and Hepatology 2008; 23(5): 707 doi: 10.1111/j.1440-1746.2008.05386.x
|
| 18 |
Fouad Yousef, Chris Cardwell, Marie M. Cantwell, Karen Galway, Brian T. Johnston, Liam Murray. The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis. American Journal of Epidemiology 2008; 168(3): 237 doi: 10.1093/aje/kwn121
|
| 19 |
Kavel Visrodia, Siddharth Singh, Rajesh Krishnamoorthi, David A. Ahlquist, Kenneth K. Wang, Prasad G. Iyer, David A. Katzka. Magnitude of Missed Esophageal Adenocarcinoma After Barrett’s Esophagus Diagnosis: A Systematic Review and Meta-analysis. Gastroenterology 2016; 150(3): 599 doi: 10.1053/j.gastro.2015.11.040
|
| 20 |
Yong Kang Lee. Barrett's Esophagus. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2022; 22(3): 177 doi: 10.7704/kjhugr.2022.0015
|
| 21 |
Anushka Baruah, Navtej S. Buttar. Chemoprevention in Barrett's oesophagus. Best Practice & Research Clinical Gastroenterology 2015; 29(1): 151 doi: 10.1016/j.bpg.2014.12.003
|
| 22 |
Ai Kubo, T. R. Levin, Gladys Block, Gregory Rumore, Charles P. Quesenberry, Patricia Buffler, Douglas A. Corley. Cigarette smoking and the risk of Barrett’s esophagus. Cancer Causes & Control 2009; 20(3): 303 doi: 10.1007/s10552-008-9244-4
|
| 23 |
J. Akiyama, A. Roorda, G. Triadafilopoulos. Managing Barrett's esophagus with radiofrequency ablation. Gastroenterology Report 2013; 1(2): 95 doi: 10.1093/gastro/got009
|
| 24 |
Farhad Navab, Brian H. Nathanson, David J. Desilets. The impact of lifestyle on Barrett’s Esophagus: A precursor to esophageal adenocarcinoma. Cancer Epidemiology 2015; 39(6): 885 doi: 10.1016/j.canep.2015.10.013
|
| 25 |
Sharmila Anandasabapathy, Jagriti Jhamb, Marta Davila, Caimiao Wei, Jeffrey Morris, Robert Bresalier. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 2007; 109(4): 668 doi: 10.1002/cncr.22451
|
| 26 |
Esther Klaver, Angela Bureo Gonzalez, Nahid Mostafavi, Rosalie Mallant‐Hent, Lucas C. Duits, Bert Baak, Clarisse J. M. Böhmer, Arnoud H. A. M. van Oijen, Ton Naber, Pieter Scholten, Sybren L. Meijer, Jacques J. G. H. M. Bergman, Roos E. Pouw. Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression. United European Gastroenterology Journal 2021; 9(8): 929 doi: 10.1002/ueg2.12114
|